SlideShare a Scribd company logo
1 of 10
CO-OP REFLECTION PRESENTATION
PROTEIN ENGINEERING AND ANTIBODY TECHNOLOGIES-
ANTIBODY DISCOVERY GROUP
SAMRITI BEDI
SUPERVISOR- JUKKA KONOLA
RESEARCH ASSISTANT CO-OP- JULY- DECEMBER 2014
EMD SERONO, BILLERICA
Outline
Overall work flow at Antibody Technology, EMD Serono
Primary role and responsibilities as a Co-op student
Assay development and optimization on 2 major formats:
ELISA
HTRF FRET
Accomplishments
Acknowledgements
Overall Workflow
3
Antigen Immunization
B cell sorting and Culturing/Cloning
Possible IgG/IgM generation
Capture ELISA to test for
presence/absence of IgG/IgMs
Target Binding ELISA to identify
target specific IgGs
Identification of clones producing
target specific IgGs
Confirmation and
further
characterization
Protein production
Primary role and responsibilities
 Developing and performing validation assays for testing reagents including target proteins and antibodies by
binding ELISA.
 Preparing 384/96 well plates coated with target proteins for a binding ELISA.
 Screening of samples by a fully automated target binding ELISA to identify target specific IgGs.
 Screening of samples by a semi-automatic or fully automatic capture ELISA to test for IgG/IgM production by B
cells.
 Performing serum titer experiments on samples by fully automatic target binding ELISA.
 MVS Performance Verification Testing of the Perkin Elmer Sciclone Liquid Handler systems.
 Developing and optimizing HTRF FRET assays for different antibody-target systems.
 Maintaining Sciclone automated liquid handler systems by Perkin Elmer on a day-to-day basis.
 Maintaining an up-to-date record of the electronic scientific notebook.
 Maintaining a database of reagent supplies within the automation lab.
ELISA Assays
Application:
Target binding
Ig expression determination
Serum titer determination
Isotype determination
Reagent validation assays
Target
Primary antibody against
target protein
Antibody against Fc part of the
primary Ab coupled with HRP
TMB Addition
TMB turns into a blue product – and stop
reagent turns it yellow for reading at
450nm
Automated ELISA system
HTRF Technology
Homogeneous Time Resolved Fluorescence
• Immunoassay based on transfer of energy between 2 fluorophores
• a donor e.g. Eu3+ or Lumi4®-Tb cryptate
• an acceptor e.g. d2
• The donor/acceptor used in HTRF emit long-lived fluorescence and hence the short lived background signals decay
6-His Tag
Target Protein
Antibody coupled with
cryptate (Donor) Antibody coupled with
D2(Acceptor)
Laser/Flash Lamp excitation
at 320nm
Detect the energy transfer
by reading at 665nm
Accomplishments
Learned to work in a corporate environment under strict EHS guidelines.
Significantly helped to move company projects further by continuously delivering results in a
timely and accurate manner.
Developed an acumen for multi-tasking and time management to meet project deadlines.
Worked independently and also in-collaboration with other group members to run various
high-throughput assays.
Developed a good understanding of the basics of the immunoassays used.
Gained experience at analyzing and presenting scientific data succinctly.
Acknowledgements
Antibody Technology Group at EMD Serono:
Jukka Konola
Youbin Wang
Xinyan Zhao
Xiubin Gu
Qingyong Ji
An Qi
Jinyang Zhang
Shruti Pratapa
Christel Iffland
Northeastern University:
Vanecia Harrison
Cynthia Bainton
Jim Leung
Other Co-op Students:
Miriam-El-Samin
Sneha Ranade
Thank you!

More Related Content

Similar to Samriti Bedi CO-OP REFLECTION PRESENTATION- Northeastern University

One-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioOne-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioGenScript ProBio
 
Koh Tze Loong CV for pharma Nov 2015
Koh Tze Loong CV for pharma Nov 2015Koh Tze Loong CV for pharma Nov 2015
Koh Tze Loong CV for pharma Nov 2015koh tze loong
 
Antibodies for Immunohistochemistry (IHC)
Antibodies for Immunohistochemistry (IHC)Antibodies for Immunohistochemistry (IHC)
Antibodies for Immunohistochemistry (IHC)Jonathan Mayali
 
PEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
PEGS Europe Protein & Antibody Engineering Summit 2014 AgendaPEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
PEGS Europe Protein & Antibody Engineering Summit 2014 AgendaNicole Proulx
 
Kurtz biomanufacturing
Kurtz biomanufacturingKurtz biomanufacturing
Kurtz biomanufacturingbio-link
 
ReaMetrix Overview
ReaMetrix OverviewReaMetrix Overview
ReaMetrix Overviewzmanian
 
Immunoassay technique 23.pdf
Immunoassay  technique 23.pdfImmunoassay  technique 23.pdf
Immunoassay technique 23.pdfNaaelHAli1
 
Therapeutic Antibody Platform
Therapeutic Antibody PlatformTherapeutic Antibody Platform
Therapeutic Antibody PlatformJonathan Mayali
 
How to Optimize Your Immunofluorescence Staining
How to Optimize Your Immunofluorescence StainingHow to Optimize Your Immunofluorescence Staining
How to Optimize Your Immunofluorescence StainingProteintech Group
 
ROLE OF IMMUNOASSAY FOR DETECTION OF NARCOTIC DRUG.pptx
ROLE OF IMMUNOASSAY FOR DETECTION OF NARCOTIC DRUG.pptxROLE OF IMMUNOASSAY FOR DETECTION OF NARCOTIC DRUG.pptx
ROLE OF IMMUNOASSAY FOR DETECTION OF NARCOTIC DRUG.pptxTereena1
 
Europass CV3P Amarish Sharma 2014-Denmark
Europass CV3P Amarish Sharma 2014-DenmarkEuropass CV3P Amarish Sharma 2014-Denmark
Europass CV3P Amarish Sharma 2014-DenmarkAmarish K Sharma
 
Viral diagnostics for animal diseases
Viral diagnostics for animal diseasesViral diagnostics for animal diseases
Viral diagnostics for animal diseaseshannahgrazia
 
Principles and Applications of ELISA
Principles and Applications of ELISAPrinciples and Applications of ELISA
Principles and Applications of ELISASubramani Parasuraman
 
Cladman, wendy cv and addendum
Cladman, wendy  cv and addendum Cladman, wendy  cv and addendum
Cladman, wendy cv and addendum Wendy Cladman
 
Molecular and Cellular Biologist_Tanima Mallik
Molecular and Cellular Biologist_Tanima MallikMolecular and Cellular Biologist_Tanima Mallik
Molecular and Cellular Biologist_Tanima MallikTanima Mallik
 
An Introduction to Immunohistochemistry
An Introduction to ImmunohistochemistryAn Introduction to Immunohistochemistry
An Introduction to ImmunohistochemistryCreative-Bioarray
 
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyProcess Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyMilliporeSigma
 
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyProcess Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyMerck Life Sciences
 

Similar to Samriti Bedi CO-OP REFLECTION PRESENTATION- Northeastern University (20)

One-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioOne-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBio
 
Koh Tze Loong CV for pharma Nov 2015
Koh Tze Loong CV for pharma Nov 2015Koh Tze Loong CV for pharma Nov 2015
Koh Tze Loong CV for pharma Nov 2015
 
Antibodies for Immunohistochemistry (IHC)
Antibodies for Immunohistochemistry (IHC)Antibodies for Immunohistochemistry (IHC)
Antibodies for Immunohistochemistry (IHC)
 
PEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
PEGS Europe Protein & Antibody Engineering Summit 2014 AgendaPEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
PEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
 
Kurtz biomanufacturing
Kurtz biomanufacturingKurtz biomanufacturing
Kurtz biomanufacturing
 
Khushbu_Simoa_06-16
Khushbu_Simoa_06-16Khushbu_Simoa_06-16
Khushbu_Simoa_06-16
 
ReaMetrix Overview
ReaMetrix OverviewReaMetrix Overview
ReaMetrix Overview
 
Immunoassay technique 23.pdf
Immunoassay  technique 23.pdfImmunoassay  technique 23.pdf
Immunoassay technique 23.pdf
 
Therapeutic Antibody Platform
Therapeutic Antibody PlatformTherapeutic Antibody Platform
Therapeutic Antibody Platform
 
How to Optimize Your Immunofluorescence Staining
How to Optimize Your Immunofluorescence StainingHow to Optimize Your Immunofluorescence Staining
How to Optimize Your Immunofluorescence Staining
 
Biology Services
Biology Services Biology Services
Biology Services
 
ROLE OF IMMUNOASSAY FOR DETECTION OF NARCOTIC DRUG.pptx
ROLE OF IMMUNOASSAY FOR DETECTION OF NARCOTIC DRUG.pptxROLE OF IMMUNOASSAY FOR DETECTION OF NARCOTIC DRUG.pptx
ROLE OF IMMUNOASSAY FOR DETECTION OF NARCOTIC DRUG.pptx
 
Europass CV3P Amarish Sharma 2014-Denmark
Europass CV3P Amarish Sharma 2014-DenmarkEuropass CV3P Amarish Sharma 2014-Denmark
Europass CV3P Amarish Sharma 2014-Denmark
 
Viral diagnostics for animal diseases
Viral diagnostics for animal diseasesViral diagnostics for animal diseases
Viral diagnostics for animal diseases
 
Principles and Applications of ELISA
Principles and Applications of ELISAPrinciples and Applications of ELISA
Principles and Applications of ELISA
 
Cladman, wendy cv and addendum
Cladman, wendy  cv and addendum Cladman, wendy  cv and addendum
Cladman, wendy cv and addendum
 
Molecular and Cellular Biologist_Tanima Mallik
Molecular and Cellular Biologist_Tanima MallikMolecular and Cellular Biologist_Tanima Mallik
Molecular and Cellular Biologist_Tanima Mallik
 
An Introduction to Immunohistochemistry
An Introduction to ImmunohistochemistryAn Introduction to Immunohistochemistry
An Introduction to Immunohistochemistry
 
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyProcess Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
 
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyProcess Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
 

Samriti Bedi CO-OP REFLECTION PRESENTATION- Northeastern University

  • 1. CO-OP REFLECTION PRESENTATION PROTEIN ENGINEERING AND ANTIBODY TECHNOLOGIES- ANTIBODY DISCOVERY GROUP SAMRITI BEDI SUPERVISOR- JUKKA KONOLA RESEARCH ASSISTANT CO-OP- JULY- DECEMBER 2014 EMD SERONO, BILLERICA
  • 2. Outline Overall work flow at Antibody Technology, EMD Serono Primary role and responsibilities as a Co-op student Assay development and optimization on 2 major formats: ELISA HTRF FRET Accomplishments Acknowledgements
  • 3. Overall Workflow 3 Antigen Immunization B cell sorting and Culturing/Cloning Possible IgG/IgM generation Capture ELISA to test for presence/absence of IgG/IgMs Target Binding ELISA to identify target specific IgGs Identification of clones producing target specific IgGs Confirmation and further characterization Protein production
  • 4. Primary role and responsibilities  Developing and performing validation assays for testing reagents including target proteins and antibodies by binding ELISA.  Preparing 384/96 well plates coated with target proteins for a binding ELISA.  Screening of samples by a fully automated target binding ELISA to identify target specific IgGs.  Screening of samples by a semi-automatic or fully automatic capture ELISA to test for IgG/IgM production by B cells.  Performing serum titer experiments on samples by fully automatic target binding ELISA.  MVS Performance Verification Testing of the Perkin Elmer Sciclone Liquid Handler systems.  Developing and optimizing HTRF FRET assays for different antibody-target systems.  Maintaining Sciclone automated liquid handler systems by Perkin Elmer on a day-to-day basis.  Maintaining an up-to-date record of the electronic scientific notebook.  Maintaining a database of reagent supplies within the automation lab.
  • 5. ELISA Assays Application: Target binding Ig expression determination Serum titer determination Isotype determination Reagent validation assays Target Primary antibody against target protein Antibody against Fc part of the primary Ab coupled with HRP TMB Addition TMB turns into a blue product – and stop reagent turns it yellow for reading at 450nm
  • 7. HTRF Technology Homogeneous Time Resolved Fluorescence • Immunoassay based on transfer of energy between 2 fluorophores • a donor e.g. Eu3+ or Lumi4®-Tb cryptate • an acceptor e.g. d2 • The donor/acceptor used in HTRF emit long-lived fluorescence and hence the short lived background signals decay 6-His Tag Target Protein Antibody coupled with cryptate (Donor) Antibody coupled with D2(Acceptor) Laser/Flash Lamp excitation at 320nm Detect the energy transfer by reading at 665nm
  • 8. Accomplishments Learned to work in a corporate environment under strict EHS guidelines. Significantly helped to move company projects further by continuously delivering results in a timely and accurate manner. Developed an acumen for multi-tasking and time management to meet project deadlines. Worked independently and also in-collaboration with other group members to run various high-throughput assays. Developed a good understanding of the basics of the immunoassays used. Gained experience at analyzing and presenting scientific data succinctly.
  • 9. Acknowledgements Antibody Technology Group at EMD Serono: Jukka Konola Youbin Wang Xinyan Zhao Xiubin Gu Qingyong Ji An Qi Jinyang Zhang Shruti Pratapa Christel Iffland Northeastern University: Vanecia Harrison Cynthia Bainton Jim Leung Other Co-op Students: Miriam-El-Samin Sneha Ranade